Cargando…
Corrigendum: Analysis of platelet parameters and activation markers in hematologic metastases of lung cancer
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595867/ https://www.ncbi.nlm.nih.gov/pubmed/31033572 http://dx.doi.org/10.1097/CM9.0000000000000244 |
Ejemplares similares
-
Analysis of platelet parameters and activation markers in hematologic metastases of lung cancer
por: Zhang, Si-Si, et al.
Publicado: (2019) -
Corrigendum to “Hematological Inflammatory Markers in Patients with Clinically Confirmed Familial Hypercholesterolemia”
por: Vaseghi, Golnaz, et al.
Publicado: (2023) -
Corrigendum to “Low-Level Laser Irradiation Exerts Antiaggregative Effect on Human Platelets Independently on the Nitric Oxide Metabolism and Release of Platelet Activation Markers”
por: Rola, Piotr, et al.
Publicado: (2018) -
Efficacy and safety of icotinib in patients with brain metastases from lung adenocarcinoma [Corrigendum]
Publicado: (2017) -
Corrigendum to “Treatment of Febrile Neutropenia and Prophylaxis in Hematologic Malignancies: A Critical Review and Update”
por: Villafuerte-Gutierrez, Paola, et al.
Publicado: (2019)